Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP2A2 encodes the sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2), a magnesium-dependent P-type ATPase that plays a critical role in maintaining intracellular calcium homeostasis. It catalyzes the translocation of calcium ions from the cytosol into the sarcoplasmic or endoplasmic reticulum lumen, coupled with ATP hydrolysis. This process is essential for muscle relaxation and contraction cycles in cardiac and skeletal muscles, as well as calcium-dependent signaling in non-muscle cells. Dysregulation or downregulation of SERCA2 is a hallmark of cardiovascular diseases, particularly heart failure and diabetic cardiomyopathy, where impaired calcium reuptake leads to diastolic and systolic dysfunction. Conversely, heterozygous loss-of-function mutations in ATP2A2 cause Darier disease, a rare skin disorder characterized by loss of keratinocyte adhesion and abnormal keratinization. In therapeutics, SERCA2a is targeted for activation by small molecules like istaroxime and gene therapies (e.g., AAV1.SERCA2) to restore cardiac function, while its inhibition by compounds like thapsigargin is explored in oncology to induce endoplasmic reticulum stress and apoptosis in cancer cells.
Activation of SERCA2a to enhance sarcoplasmic reticulum calcium reuptake (improving cardiac relaxation and contractility in heart failure), or inhibition of SERCA2 to disrupt intracellular calcium homeostasis, triggering endoplasmic reticulum stress and apoptosis (used as an anti-tumor strategy).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SERCA2).